December 3, 2024 - 22:10

In a recent analysis, chart analyst and investor Todd Gordon provided insights into the stock performance of Hims & Hers Health, suggesting that it could potentially double in value. Gordon's examination of the stock charts indicates a bullish trend, highlighting key patterns that may signal future growth for the health-care company.
Hims & Hers Health, known for its telehealth services and wellness products, has been gaining traction in the market. Gordon pointed out several technical indicators that support the notion of upward momentum. He emphasized the importance of monitoring specific price levels and volume trends, which could serve as crucial benchmarks for investors looking to capitalize on potential gains.
As the health-care sector continues to evolve, companies like Hims & Hers are at the forefront of innovative solutions. Investors are keenly watching market dynamics, and Gordon's analysis adds a layer of optimism for those considering positions in this promising stock.
August 26, 2026 - 02:33
Faulkner University Awarded More Than $3 Million to Transform Rural Health Care Access and Workforce Development in AlabamaFaulkner University has secured more than $3 million in funding through Alabama`s Rural Health Transformation Program to expand medical services and train a new generation of health care workers...
August 25, 2026 - 13:39
Drug mix-up at Ascension impacts at least 4 surgeries, leaves 1 patient paralyzedHospital officials are working to determine how a contaminated anesthetic may have reached operating rooms, after at least four joint replacement procedures were impacted and one patient was left...
August 24, 2026 - 17:16
Alfalfa sprouts linked to food poisoning in 15 states, officials sayFederal health authorities have identified alfalfa sprouts as the likely source of a multi-state food poisoning outbreak that has now reached 15 states. The Centers for Disease Control and...
August 24, 2026 - 15:42
FDA digital health leader promises generative AI regulatory guidance is comingThe U.S. Food and Drug Administration is preparing to release formal guidance on how it will regulate generative artificial intelligence used in medical devices, according to Rick Abramson, the...